Tacrolimus-eluting stent with biodegradable polymer is more effective than sirolimus- and everolimus-eluting stent in rabbit iliac artery restenosis model

被引:6
作者
Park, Dae Sung [1 ,2 ]
Park, Jun-Kyu [3 ]
Jeong, Myung Ho [1 ,2 ]
Bae, In-Ho [1 ,2 ]
Lee, So-Youn [1 ,2 ]
Jang, Eun Jae [1 ,2 ]
Lim, Kyung-Seob [1 ,2 ]
Kim, Jong Min [1 ,2 ]
Kim, Jung Ha [1 ,2 ]
Hyun, Dae Young [1 ,2 ]
Jeong, Yun Ah [1 ,2 ]
Kim, Hyun Kuk [1 ,2 ]
Sim, Doo Sun [1 ,2 ]
机构
[1] Korea Cardiovasc Stent Inst, Jangseong Gun 501893, Jeonnam, South Korea
[2] Chonnam Natl Univ Hosp, Minist Hlth & Welf, Cardiovasc Convergence Res Ctr, Kwangju 501757, South Korea
[3] CGBio Co Ltd, Jangseong Gun 501893, Jeonnam, South Korea
关键词
tacrolimus; sirolimus; everolimus; stent; restenosis; 3-DIMENSIONAL INTRAVASCULAR ULTRASOUND; INTRACORONARY BETA-RADIATION; VASCULAR SMOOTH-MUSCLE; BARE METAL STENT; RANDOMIZED-TRIAL; RAPAMYCIN AY-22,989; INHIBITS RECURRENCE; CORONARY-ARTERIES; ENDOTHELIAL-CELLS; COATED STENTS;
D O I
10.1007/s13233-015-3139-5
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Drug-eluting stents, which are widely used in percutaneous coronary intervention, are fabricated with various considerations, such as drugs, design, polymers, and coating techniques. The aim of this study was to compare tacrolimus-eluting stents (TES), sirolimus-eluting stents (SES) and everolimus-eluting stents (EES) under identical conditions. Poly(lactic-co-glycolic acid) (PLGA) biodegradable polymer was used to coat bare metal stents (Chonnam National University Hospital Stent, CNUH Stent) with the drugs in all fabricating procedures with an ultrasonic stent-coating machine. Surface morphologies of the stents were investigated by scanning electron microscopy. The effect of drugs released from stents on rat smooth muscle and human umbilical vein endothelial cells was examined by MTT assay. The stents were implanted in rabbit iliac arteries randomly, with either TES (n=10), SES (n=10), or EES (n=10). After six weeks of implantation, the stents were isolated and subjected to histopathological analysis. Cell viability decreased in a dose-dependent manner. The surface morphologies of the stents showed a smooth and uniform shape. The release patterns of the stents showed similar profiles over 30 days. There were no significant differences in the injury score, internal elastic lamina, lumenal area, neointimal area, percent area stenosis, and inflammation score among the three groups. However, there was a significant difference in the fibrin score (0.6 +/- 0.44 in the TES, vs. 0.8 +/- 0.48 in the SES, vs. 0.8 +/- 0.61 in the EES, n=10, p < 0.05). This study showed that tacrolimus was not inferior to sirolimus (SRL) and everolimus (EVL). Moreover, tacrolimus (TCL) is more effective in decreasing the fibrin score. Therefore, tacrolimus can be a useful alternative drug for fabricating drug-eluting stents.
引用
收藏
页码:1034 / 1041
页数:8
相关论文
共 50 条
[41]   Poly-l-lactide Polymer-Based Triple Drug-Eluting Stent with Abciximab, Alpha-Lipoic Acid and Sirolimus in Porcine Coronary Restenosis Model [J].
Park, Jun-Kyu ;
Kim, Sung Soo ;
Kim, Hyun Kuk ;
Nah, Jae-Woon ;
Kim, Han Byul ;
Bae, In Ho ;
Park, Dae Sung ;
Shim, Jae Won ;
Lee, Min Young ;
Kim, Joong Sun ;
Koo, Bon-Sang ;
Jeong, Kang-Jin ;
Jin, Yeong Bae ;
Kim, Sun-Uk ;
Lee, Sang-Rae ;
Na, Joo-Young ;
Sim, Doo Sun ;
Hong, Young Joon ;
Lim, Kyung Seob ;
Jeong, Myung Ho .
MACROMOLECULAR RESEARCH, 2020, 28 (01) :9-14
[42]   Polymer-Free Biolimus A9-Coated Stent Demonstrates More Sustained Intimal Inhibition, Improved Healing, and Reduced Inflammation Compared With a Polymer-Coated Sirolimus-Eluting Cypher Stent in a Porcine Model [J].
Tada, Norio ;
Virmani, Renu ;
Grant, Gordon ;
Bartlett, Lauren ;
Black, Alexander ;
Clavijo, Claudia ;
Christians, Uwe ;
Betts, Ron ;
Savage, Doug ;
Su, Shih-Horng ;
Shulze, John ;
Kar, Saibal .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (02) :174-183
[43]   Experimental evaluation of efficacy and healing response of everolimus-eluting stents in the familial hypercholesterolemic swine model: a comparative study of bioabsorbable versus durable polymer stent platforms [J].
Tellez, Armando ;
Seifert, Paul S. ;
Donskoy, Elina ;
Sushkova, Natalia ;
Pennington, Douglas E. ;
Milewski, Krzysztof ;
Krueger, Christian G. ;
Kaluza, Greg L. ;
Eppihimer, Michael J. ;
Huibregtse, Barbara A. ;
Dawkins, Keith D. ;
Granada, Juan F. .
CORONARY ARTERY DISEASE, 2014, 25 (03) :198-207
[44]   Drug-Eluting Stents for the Treatment of Left Main Coronary Artery Disease with Bifurcated Lesions: a Comparison with Sirolimus, Paclitaxel, Zotarolimus (Endeavor Resolute), BiolimusA9, EPC Capture and Everolimus-Eluting Stent: Multicenter Registry in Asia [J].
Nakamura, Sunao ;
Ogawa, Hisao ;
Bae, Jang-Ho ;
Cahyadi, Yeo H. ;
Udayachalerm, Wasan ;
Tresukosol, Damras ;
Tansuphaswadikul, Sudaratana .
CIRCULATION, 2011, 124 (21)
[45]   A Novel Polymer-Free Ciglitazone-Eluting Stent Inhibits Neointimal Proliferation Stronger than Sirolimus-Eluting Stents: An Experimental Study Using Optical Coherence Tomography in Rabbit Iliacal Arteries [J].
Poerner, Tudor C. ;
Otto, Sylvia ;
Bischoff, Sabine ;
Muehlstaedt, Diana ;
Goebel, Bjoern ;
Jung, Christian ;
Figulla, Hans R. .
CIRCULATION, 2010, 122 (21)
[46]   Multivariable prediction model to estimate the probability of restenosis at proximal edge after 2nd-generation drug-eluting-stent implantation: development and internal validation using a quantitative coronary angiography from the post-marketing surveillance studies of everolimus-eluting stent in Japan [J].
Kozuma, Kayoko ;
Kozuma, Ken ;
Shinozaki, Tomohiro ;
Kashiwabara, Kosuke ;
Oba, Koji ;
Matsuyama, Yutaka .
CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2021, 36 (02) :190-197
[47]   Multivariable prediction model to estimate the probability of restenosis at proximal edge after 2nd-generation drug-eluting-stent implantation: development and internal validation using a quantitative coronary angiography from the post-marketing surveillance studies of everolimus-eluting stent in Japan [J].
Kayoko Kozuma ;
Ken Kozuma ;
Tomohiro Shinozaki ;
Kosuke Kashiwabara ;
Koji Oba ;
Yutaka Matsuyama .
Cardiovascular Intervention and Therapeutics, 2021, 36 :190-197
[48]   Outcomes of biodegradable polymer sirolimus-eluting PROLIM stent in patients with coronary artery disease. Results of 12-month follow-up of prospective registry [J].
Roleder, Tomasz ;
Smolka, Grzegorz ;
Podolecka, Ewa ;
Chudek, Jolanta ;
Dworowy, Sebastian ;
Zelazowska, Katarzyna ;
Wojakowski, Wojciech ;
Ochala, Andrzej .
KARDIOLOGIA POLSKA, 2016, 74 (05) :411-417
[49]   A novel polymer-free drug-eluting stent coated with everolimus using nitrogen-doped titanium dioxide film deposition in a porcine coronary restenosis model [J].
Sim, Doo Sun ;
Jeong, Myung Ho ;
Park, Dae Sung ;
Kim, Jung Ha ;
Lim, Kyung Seob ;
Bae, In Ho ;
Zhehao, Piao ;
Yang, Hae Young ;
Lee, Je Hoon ;
Hyun, Dae Young ;
Hong, Young Joon ;
Kim, Ju Han ;
Ahn, Youngkeun ;
Kang, Jung Chaee .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 :436-440
[50]   Poly-l-lactide Polymer-Based Triple Drug-Eluting Stent with Abciximab, Alpha-Lipoic Acid and Sirolimus in Porcine Coronary Restenosis Model [J].
Jun-Kyu Park ;
Sung Soo Kim ;
Hyun Kuk Kim ;
Jae-Woon Nah ;
Han Byul Kim ;
In Ho Bae ;
Dae Sung Park ;
Jae Won Shim ;
Min Young Lee ;
Joong Sun Kim ;
Bon-Sang Koo ;
Kang-Jin Jeong ;
Yeong Bae Jin ;
Sun-Uk Kim ;
Sang-Rae Lee ;
Joo-Young Na ;
Doo Sun Sim ;
Young Joon Hong ;
Kyung Seob Lim ;
Myung Ho Jeong .
Macromolecular Research, 2020, 28 :9-14